Emad El-Omar

Appearances

GENOTYPIC RESISTANCE GUIDED THERAPY VERSUS SUSCEPTIBILITY TESTING GUIDED THERAPY IN THE FIRST-LINE AND THIRD-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION-TWO MULTICENTER RANDOMIZED CONTROLLED TRIALS
Date
May 6, 2023
INTRODUCTION. Our previous study reported a significant increase in metachronous recurrence of early gastric cancer after endoscopic submucosal dissection due to CD44v9-positive cancer stem-like cells in _H. pylori_-infected stomach tissue (_BR. J. CANCER_ 109:379, 2013)…
Presenter
Jyh-Ming Liou
Speakers
Mei-Jyh Chen
Po-Yueh Chen
Chieh-Chang Chen
Jaw-Town Lin
Emad El-Omar
Ming-Shiang Wu
COMPARISON OF EMPIRICAL THERAPY VERSUS SUSCEPTIBILITY TESTING-GUIDED THERAPY FOR REFRACTORY HELICOBACTER PYLORI INFECTION: A MULTICENTER, OPEN-LABEL, RANDOMIZED CONTROLLED, NON-INFERIORY TRIAL
Date
May 21, 2024
BACKGROUND AND AIMS: There is limited evidence to support whether optimized empirical therapy can be an alternative to susceptibility testing guided therapy for patients with refractory _Helicobacter pylori_ (_H. pylori_) infection defined as failure after two or more eradication attempts…
Presenter
Jyh-Ming Liou
Speakers
Mei-Jyh Chen
Chieh-Chang Chen
Jaw-Town Lin
Emad El-Omar
Ming-Shiang Wu